Healthcare Cost Intelligence

Govern your
health spend.
With precision.

Malaysia's benchmark-based health cost governance platform — quantifying spend leakage, establishing pricing benchmarks, and delivering actionable cost intelligence.

RM 686k+
Modelled savings
73%
Chronic drug share
5,548
Claims analysed
Live Preview
Your cost profile
Covered employees500
Chronic cohort30%
Generic substitution40%
Projected annual savings
RM 234,140
RM 39 / employee / month
Commissioned analysis — Statutory Government Agency, 2025
Total spend analysed
RM 1.39M
Medication share
88%
Chronic drug spend
RM 895k
Claims analysed
5,548
Architecture

Three stacked engines

Most platforms build dashboards. DAULAT is built on a different premise — that the entity which controls the data-generating infrastructure controls the intelligence layer. No transactions means no data. No data means no policy relevance.

Layer 1 · Hidden Infrastructure
Transaction Engine
Powered by Tigas
Prescription capture
Pharmacy fulfilment
Medication adherence tracking
Refill behaviour logging

This is the foundation layer. Without it, DAULAT is just another analytics platform. Controlling the dispensing transaction network is what makes the intelligence proprietary — and irreplaceable.

Layer 2 · Visible to Clients
Cost Intelligence Engine
This is DAULAT
Medication spend analysis
Chronic disease cluster mapping
PEPM cost benchmarking
National employer dashboards

The layer employers, HR directors, and insurers interact with. It earns trust, demonstrates value, and creates the access that deepens the transaction dataset underneath.

Layer 3 · Semi-Visible to Government
DRG Simulation Engine
Policy infrastructure
ICD-10 disease coding
Drug utilisation patterns
Episode cost modelling
DRG reimbursement scenarios

The policy translation layer. Helps MOH simulate what happens to national health spend when payment incentives change — answering the question governments always ask before committing to reform.

Commercial Engagement Stages
01
Cost Intelligence Audit
6-month claims data collection. PEPM mapping across drug categories, chronic cohorts, and vendor pricing.
02
Benchmark Report
Quantified Cost Intelligence Report with drug inflation heat-map, savings pathways, and dispute analysis.
03
Platform & Advisory
Ongoing DAULAT access for HR and HQ. Formulary governance, LTM pharmacy fulfilment, and PEPM tracking.
04
Incentivised Prevention
Biometric screening programmes that shift employees from reactive treatment to preventive behaviour.
Intelligence

The real competitive moat is not AI. It is data exhaust from medication dispensing.

Every dispensing transaction is a data event. Aggregated at scale, these events form the national medication trajectory dataset — capturing what hospitals rarely see and what no dashboard can fabricate.

Each Transaction Produces
PrescriptionDisease prevalence signal
Drug classProtocol adherence pattern
Refill timingAdherence vs dropout rate
Drug switchTreatment failure marker
DurationChronic burden trajectory
How National Systems Are Built
System
What They Show
Real Engine
US PBMsDrug price savingsClaims + pharmacy network
NHS AnalyticsQuality dashboardsGP data capture
Singapore MOHHealth analyticsNational billing systems
DAULATCost intelligenceDispensing transaction network
DRG Simulation — Why It Matters

Answering the question every government asks before committing to reform

Diagnosis-Related Group simulation translates the claims and prescribing dataset into payment policy scenarios. It quantifies — at population scale — what happens to national health expenditure when reimbursement incentives change. This is where DAULAT transitions from employer tool to policy infrastructure.

Example Simulation · Hypertension
Current model
RM 900
per patient / year
Protocol-optimised model
RM 550
per patient / year
Patient population2 million
Potential annual savingsRM 700M
Platform Capabilities
📊
Cost Intelligence
Portfolio-wide PEPM benchmarking, drug inflation heat-maps, and chronic medication concentration analysis.
⚖️
Benchmark Governance
Dispute transparency through benchmark adjudication aligned to MyPriMe, FUKKM, and MyHDW national signals.
💊
Generic Optimisation
Formulary discipline through therapeutic substitution. LTM diversion from panel clinics to pharmacy networks.
🗺️
State-Level Heatmap
Peninsular Malaysia pricing variance benchmarking to identify where governance intervention is most urgent.
🔒
Sovereign Data Posture
No raw patient records stored. Aligned to NCII compliance — reference indices and aggregated variance only.
📋
Board-Ready Reporting
RICE scoring, Board Readiness index, and 5 actionable management recommendations generated instantly.
Simulation Engine

Model your organisation's savings

Adjust the inputs below, then click Generate Report for a full branded PDF-ready strategic report.

Your Inputs
Covered employees500
Chronic disease cohort30%
Generic substitution rate40%
Cost Parameters
Annual clinic medical cost (RM)2,800
Annual drug cost / employee (RM)1,200
Projected annual savings
RM 234,140
RM 39 / employee / month
Status quo PEPM
RM 383
DAULAT PEPM
RM 344
Clinic saving
−6.4%
Drug saving
−10.0%
Chronic spend by NCD category
DiabetesRM 680,165
Innovator 81%Generic 19%
HypertensionRM 572,706
Innovator 81%Generic 19%
CardiovascularRM 537,294
Innovator 81%Generic 19%
Total chronic spendRM 1,790,165
▲ Claim exceeds benchmark
+RM 800 variance
vs RM 140 national benchmark reference
Generate your strategic report
Full branded report with savings breakdown, NCD analysis & 5 management actions. Download as PDF.

Ready to reclaim your health spend?

Speak with a MyTigas specialist. We'll audit your PEPM and model benchmark-aligned savings.

DAULATby Tigas Pharma (M) Sdn. Bhd.
© 2026 Tigas Pharma · vengfoon.loh@tigaspharma.com.my